CenExel Taps Neurology Specialist as Lead PI for Key Alzheimer's Research Site
Event summary
- CenExel appoints Dr. Arun Singh as Primary Principal Investigator for its Toms River clinical research site on April 29, 2026.
- Dr. Singh previously served as sub-PI at Advanced Memory Research Institute since September 2019.
- Toms River site is the largest Alzheimer's disease research facility in the Northeast.
- Appointment strengthens CenExel's presence in New Jersey and expands access to neurological research.
The big picture
This appointment underscores CenExel's focus on building specialized centers of excellence for Alzheimer's and memory disorders research. The move comes as demand grows for high-quality sites capable of conducting complex neurological trials, particularly with an aging population driving increased R&D in dementia treatments.
What we're watching
- Site Expansion Strategy
- How CenExel will leverage Dr. Singh's expertise to grow its Alzheimer's research capabilities in the Northeast.
- Patient Recruitment
- Whether the appointment can accelerate patient enrollment and retention at the Toms River site.
- Competitive Positioning
- The pace at which CenExel can differentiate itself from other clinical research networks in neurological studies.
Related topics